+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Device Analytical Testing Outsourcing Market - Global Forecast 2026-2032- Product Image
Medical Device Analytical Testing Outsourcing Market - Global Forecast 2026-2032- Product Image
Sale

Medical Device Analytical Testing Outsourcing Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674825
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Medical Device Analytical Testing Outsourcing Market is projected to reach USD 7.98 Billion in 2026. It is expected to continue growing at a CAGR of 8.77%, reaching USD 13.38 Billion by 2032.

Medical device analytical testing outsourcing has become a strategic operating model for manufacturers that need faster, evidence-ready validation across biocompatibility, chemical characterization, microbiology, sterility assurance, packaging integrity, extractables and leachables, toxicology, particulate analysis, and materials characterization.

Demand is supported by documented regulatory expectations from the U.S. FDA, the European Commission, ISO, ASTM, USP, OECD, and other recognized standards bodies. As devices become more complex through combination products, connected hardware, implantable materials, drug-device interfaces, and minimally invasive technologies, sponsors increasingly rely on ISO/IEC 17025-accredited and GLP-capable laboratories to generate defensible data for submissions, audits, design changes, complaint investigations, and post-market surveillance.

Transformative Shifts in Analytical Testing Outsourcing

The outsourcing landscape is shifting from transactional testing toward integrated evidence generation. Device manufacturers are consolidating vendors that can support ISO 10993 biological evaluation, ISO 11607 packaging validation, sterility assurance, particulate testing, accelerated and real-time aging, electrical safety interfaces, and chemical characterization under a single quality framework.

Regulatory modernization is also reshaping demand. The FDA Quality Management System Regulation final rule aligns U.S. device quality requirements more closely with ISO 13485, with enforcement beginning in 2026. In Europe, MDR and IVDR continue to intensify technical documentation, performance evaluation, clinical evidence, and post-market surveillance expectations, strengthening the case for specialist analytical testing partners with audit-ready systems and globally accepted methods.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to improve laboratory productivity, data review, deviation detection, method development, and documentation control in medical device analytical testing outsourcing. AI-enabled analytics can help identify outliers in chromatography, spectroscopy, environmental monitoring, bioburden, stability, and aging datasets, while laboratory information management systems support traceability, audit trails, sample tracking, and faster certificate generation.

The cumulative impact is operational rather than purely automated: AI can reduce manual review burden, improve trend visibility, support risk-based decision-making, and strengthen data consistency, but regulated testing still requires validated methods, qualified instruments, human scientific oversight, data integrity controls, and compliance with applicable FDA, ISO, OECD GLP, EU MDR, EU IVDR, and regional quality expectations.

Key Regional Insights Across Major Markets

Asia-Pacific is expanding as both a manufacturing base and a testing demand center, led by China, India, Japan, South Korea, Australia, and ASEAN markets where local device production, clinical adoption, and regulatory capacity are growing. The region’s demand is reinforced by rising use of implantable, diagnostic, connected, and minimally invasive devices, along with greater attention to ISO-aligned biocompatibility, sterilization, and packaging evidence. North America remains a high-value outsourcing hub because U.S. and Canadian manufacturers require strong FDA, Health Canada, ISO, USP, and ASTM-aligned evidence packages, particularly for complex devices, combination products, software-enabled hardware, and lifecycle changes.

Europe is shaped by MDR and IVDR compliance, notified body scrutiny, and the need for robust biological safety, sterilization, performance, usability, and post-market documentation. Latin America, especially Brazil and Mexico, is advancing through healthcare investment, imported-device oversight, and expanding device registrations that require reliable analytical evidence. The Middle East is gaining traction through hospital infrastructure, localization policies, and regulatory strengthening across Gulf markets, while Africa shows emerging demand tied to public health procurement, diagnostics, donor-funded healthcare programs, and imported-device quality assurance.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is benefiting from medical technology manufacturing diversification, regional trade integration, and harmonization efforts that encourage more consistent conformity assessment and quality documentation. The GCC is strengthening demand through healthcare infrastructure expansion, procurement modernization, medical technology localization, and regulatory alignment initiatives across Saudi Arabia, the United Arab Emirates, and neighboring markets, increasing the need for validated testing records that support product registration and hospital purchasing requirements.

The European Union remains one of the most technically demanding environments due to MDR and IVDR requirements, making outsourced testing essential for evidence completeness, technical file readiness, biological evaluation, and post-market obligations. BRICS markets combine large patient populations with expanding manufacturing capabilities and evolving regulatory systems, creating sustained need for biocompatibility, sterility, performance, and materials testing. G7 countries lead high-value innovation, advanced regulatory science, and stringent quality expectations, while NATO markets add demand linked to resilient supply chains, dual-use technologies, emergency preparedness, and trusted testing networks for critical healthcare products.

Key Country Insights for Medical Device Testing Outsourcing

The United States is a leading center for high-complexity medical device testing demand, supported by FDA oversight, recognized consensus standards, quality-system expectations, and a deep medtech innovation base. Canada emphasizes Health Canada licensing, ISO 13485-based quality-system requirements, and strong documentation practices, while Mexico benefits from nearshoring, maquiladora manufacturing, and North American supply-chain integration. Brazil remains Latin America’s anchor market because ANVISA requirements, domestic healthcare demand, and imported-device controls increase the need for reliable analytical evidence.

In Europe, the United Kingdom, Germany, France, Italy, and Spain generate strong demand under UKCA, CE marking, MDR, IVDR, and ISO-aligned frameworks, with Germany and France especially active in advanced engineering, diagnostics, and hospital technology adoption. Russia maintains localized registration and conformity requirements that make documentation planning important for market access. China, India, Japan, Australia, and South Korea are central to Asia-Pacific growth, combining regulatory modernization, advanced manufacturing, local testing capacity, and rising adoption of connected, implantable, diagnostic, orthopedic, cardiovascular, and minimally invasive devices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize outsourced testing partners with ISO/IEC 17025 accreditation, GLP capability where applicable, validated methods, strong chain-of-custody controls, qualified instruments, secure data systems, and proven experience with FDA, MDR, IVDR, Health Canada, PMDA, NMPA, CDSCO, TGA, ANVISA, UKCA, and MFDS expectations. Vendor qualification should assess scientific depth, turnaround reliability, audit readiness, data integrity, cybersecurity, deviation management, and the ability to support global submissions.

Manufacturers can improve speed and compliance by engaging testing partners earlier in design control, material selection, sterilization strategy, packaging design, extractables and leachables planning, toxicological risk assessment, and ISO 14971 risk management. Building master service agreements, harmonized test plans, standardized reporting templates, and digital data exchange can reduce retesting, improve regulatory consistency, strengthen lifecycle management, and support faster response to notified body or regulator questions.

Research Methodology

This executive summary is built from a standards-led research approach using publicly available regulatory guidance, recognized consensus standards, quality-system requirements, and industry evidence from medical device conformity assessment. Key reference frameworks include FDA device guidance, ISO 10993, ISO 13485, ISO 14971, ISO/IEC 17025, ISO 11607, ASTM and USP methods, EU MDR, EU IVDR, OECD GLP principles, and regional regulatory requirements.

The analysis evaluates demand drivers, outsourcing models, laboratory capabilities, regional regulatory dynamics, quality-system expectations, and technology adoption patterns. Findings are synthesized to support strategic decision-making for manufacturers, contract laboratories, investors, and healthcare technology suppliers while avoiding unsupported market estimation, market sizing, market share, or forecasting claims.

Conclusion

Medical device analytical testing outsourcing is becoming essential to regulatory readiness, product safety, quality assurance, and global market access. The sector is supported by stricter evidence expectations, complex device designs, expanding regional regulations, increased scrutiny of biological safety and sterility assurance, and the need for accredited laboratory capacity.

Organizations that treat outsourced testing as a strategic quality and regulatory function-rather than a late-stage compliance task-are better positioned to reduce approval risk, accelerate submissions, maintain product performance, and support compliant lifecycle management across diverse international markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Device Analytical Testing Outsourcing Market, by Testing Type
7.1. Introduction
7.2. Extractables & Leachables (E&L) Testing
7.2.1. Organic Extractables
7.2.2. Inorganic Extractables
7.3. Material Characterization
7.4. Bioburden & Sterility Testing
7.4.1. Bioburden Quantification
7.4.2. Sterility Validation
7.4.3. Bacterial Endotoxin Testing
7.5. Packaging Integrity & Shelf-Life Testing
7.6. Biocompatibility Testing
7.7. Contaminant & Residue Analysis
8. Medical Device Analytical Testing Outsourcing Market, by Device Class
8.1. Introduction
8.2. Class I
8.3. Class II
8.4. Class III
9. Medical Device Analytical Testing Outsourcing Market, by Device Type
9.1. Introduction
9.2. Diagnostics
9.3. Drug Delivery Devices
9.4. Implants
9.4.1. Cardiovascular Implants
9.4.2. Dental Implants
9.4.3. Orthopedic Implants
9.5. Monitoring Equipment
9.6. Surgical Instruments
10. Medical Device Analytical Testing Outsourcing Market, by Test Phase
10.1. Introduction
10.2. Clinical
10.2.1. Phase I
10.2.2. Phase II
10.2.3. Phase III
10.2.4. Phase IV
10.3. Preclinical
11. Medical Device Analytical Testing Outsourcing Market, by Technology
11.1. Introduction
11.2. Chromatography
11.2.1. Gas Chromatography
11.2.2. High Performance Liquid Chromatography
11.3. Mass Spectrometry
11.4. Microscopy
11.5. Spectroscopy
12. Medical Device Analytical Testing Outsourcing Market, by Therapeutic Area
12.1. Introduction
12.2. Cardiovascular Devices
12.2.1. Stents & Catheters
12.2.2. Pacemakers & Defibrillators
12.3. Diagnostic Imaging Devices
12.4. Orthopedic & Spinal Devices
12.5. Drug-Device Combination Products
13. Medical Device Analytical Testing Outsourcing Market, by End User
13.1. Introduction
13.2. Contract Research Organizations
13.3. Hospitals & Clinics
13.4. Medical Device Manufacturers
13.5. Research & Academic Institutes
14. Medical Device Analytical Testing Outsourcing Market, by Region
14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa
15. Medical Device Analytical Testing Outsourcing Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Medical Device Analytical Testing Outsourcing Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Applus Services, S.A.
18.2. BioAgilytix Labs, LLC
18.3. BSI Group
18.4. Bureau Veritas SA
18.5. Charles River Laboratories International, Inc.
18.6. CSA Group
18.7. DEKRA SE
18.8. DNV GL AS
18.9. Element Materials Technology Group Limited
18.10. Eurofins Scientific SE
18.11. Frontage Laboratories, Inc.
18.12. ICON Public Limited Company
18.13. Intertek Group plc
18.14. Laboratory Corporation of America Holdings
18.15. Medistri SA
18.16. Nelson Laboratories, LLC
18.17. North American Science Associates, LLC
18.18. NSF International
18.19. Pace Analytical Services, LLC
18.20. SGS Société Générale de Surveillance SA
18.21. Smithers Group, Inc.
18.22. Sotera Health Company
18.23. Toxikon Corporation
18.24. TÜV Rheinland AG
18.25. TÜV SÜD AG
18.26. UL Solutions Inc.
18.27. WuXi AppTec Co., Ltd.
List of Figures
FIGURE 1. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL EXTRACTABLES & LEACHABLES (E&L) TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL EXTRACTABLES & LEACHABLES (E&L) TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL EXTRACTABLES & LEACHABLES (E&L) TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ORGANIC EXTRACTABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ORGANIC EXTRACTABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ORGANIC EXTRACTABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL INORGANIC EXTRACTABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL INORGANIC EXTRACTABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL INORGANIC EXTRACTABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL MATERIAL CHARACTERIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MATERIAL CHARACTERIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MATERIAL CHARACTERIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BIOBURDEN & STERILITY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BIOBURDEN & STERILITY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BIOBURDEN & STERILITY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL BIOBURDEN QUANTIFICATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL BIOBURDEN QUANTIFICATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL BIOBURDEN QUANTIFICATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL STERILITY VALIDATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL STERILITY VALIDATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL STERILITY VALIDATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL BACTERIAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL BACTERIAL ENDOTOXIN TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL BACTERIAL ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PACKAGING INTEGRITY & SHELF-LIFE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL PACKAGING INTEGRITY & SHELF-LIFE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PACKAGING INTEGRITY & SHELF-LIFE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CONTAMINANT & RESIDUE ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CONTAMINANT & RESIDUE ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CONTAMINANT & RESIDUE ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CLASS I MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CLASS I MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CLASS I MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CLASS II MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CLASS II MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CLASS II MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CLASS III MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CLASS III MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CLASS III MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MONITORING EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MONITORING EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MONITORING EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SURGICAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CLINICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CLINICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CLINICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PHASE I MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL PHASE I MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL PHASE I MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL PHASE II MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL PHASE II MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL PHASE II MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PHASE III MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL PHASE III MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PHASE III MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PHASE IV MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PHASE IV MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PHASE IV MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL PRECLINICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PRECLINICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL PRECLINICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL HIGH PERFORMANCE LIQUID CHROMATOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL HIGH PERFORMANCE LIQUID CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL HIGH PERFORMANCE LIQUID CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL MICROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL MICROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL MICROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL SPECTROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL SPECTROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL STENTS & CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL STENTS & CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL STENTS & CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL PACEMAKERS & DEFIBRILLATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL PACEMAKERS & DEFIBRILLATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL PACEMAKERS & DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL ORTHOPEDIC & SPINAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL ORTHOPEDIC & SPINAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL ORTHOPEDIC & SPINAL DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 186. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 187. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 188. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 189. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 190. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 191. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 192. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 193. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 194. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 195. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 196. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 197. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 198. EUROPE MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 206. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 207. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 208. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 209. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 214. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 215. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 216. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 217. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 218. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 219. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 220. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 221. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 222. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 223. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 224. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 225. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 226. AFRICA MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 228. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 229. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 230. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 231. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 232. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 233. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 234. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 235. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 236. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 237. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 238. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 239. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 240. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 241. ASEAN MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 242. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 243. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 244. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 245. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 246. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 247. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 248. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 249. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 250. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 251. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 253. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 254. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 255. GCC MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 270. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 271. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 272. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 273. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 274. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 275. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 276. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 277. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 278. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 279. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 280. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 281. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 282. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 283. BRICS MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 285. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 286. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 287. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 288. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 289. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 290. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 291. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 292. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 293. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 294. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, 2017-2032 (USD MILLION)
TABLE 295. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 296. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2017-2032 (USD MILLION)
TABLE 297. G7 MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. NATO MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 299. NATO MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TYPE, 2017-2032 (USD MILLION)
TABLE 300. NATO MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLES & LEACHABLES (E&L) TESTING, 2017-2032 (USD MILLION)
TABLE 301. NATO MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOBURDEN & STERILITY TESTING, 2017-2032 (USD MILLION)
TABLE 302. NATO MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE CLASS, 2017-2032 (USD MILLION)
TABLE 303. NATO MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 304. NATO MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPLANTS, 2017-2032 (USD MILLION)
TABLE 305. NATO MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TEST PHASE, 2017-2032 (USD MILLION)
TABLE 306. NATO MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, 2017-2032 (USD MILLION)
TABLE 307. NATO MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 308. NATO MEDICAL DEVICE ANALYTICAL TESTING OU

Companies Mentioned

  • Applus Services, S.A.
  • BioAgilytix Labs, LLC
  • BSI Group
  • Bureau Veritas SA
  • Charles River Laboratories International, Inc.
  • CSA Group
  • DEKRA SE
  • DNV GL AS
  • Element Materials Technology Group Limited
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc.
  • ICON Public Limited Company
  • Intertek Group plc
  • Laboratory Corporation of America Holdings
  • Medistri SA
  • Nelson Laboratories, LLC
  • North American Science Associates, LLC
  • NSF International
  • Pace Analytical Services, LLC
  • SGS Société Générale de Surveillance SA
  • Smithers Group, Inc.
  • Sotera Health Company
  • Toxikon Corporation
  • TÜV Rheinland AG
  • TÜV SÜD AG
  • UL Solutions Inc.
  • WuXi AppTec Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.98 Billion
Forecasted Market Value ( USD ) by 2032 $ 13.38 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Preclinical Medical Device Testing Services Market - Global Forecast 2026-2032 - Product Image

Preclinical Medical Device Testing Services Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Medical Device Outsourcing Market - Global Forecast 2026-2032 - Product Image

Medical Device Outsourcing Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Extractable and Leachable Testing Services - Global Strategic Business Report - Product Image

Extractable and Leachable Testing Services - Global Strategic Business Report

  • Report
  • 272 Pages
  • Global
From
Medical Device Outsourcing Market Size, Share & Trends Analysis Report by Class Type, Service, Application, Region, and Segment Forecasts, 2026-2033 - Product Image

Medical Device Outsourcing Market Size, Share & Trends Analysis Report by Class Type, Service, Application, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
U.S. Medical Device Testing Services Market Size, Share & Trends Analysis Report by Service (Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing, Package Validation), Phase (Preclinical, Clinical), and Growth Forecasts, 2025-2033 - Product Image

U.S. Medical Device Testing Services Market Size, Share & Trends Analysis Report by Service (Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing, Package Validation), Phase (Preclinical, Clinical), and Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • United States
From

About the Outsourced Medical Device Testing Market

The Outsourced Medical Device Testing market is a subset of the Medical Devices industry, which encompasses a wide range of products used in the diagnosis, monitoring, and treatment of medical conditions. Outsourced Medical Device Testing is a service provided by third-party companies to medical device manufacturers, allowing them to outsource the testing of their products. This service is used to ensure that the device meets the necessary safety and performance standards before it is released to the market. Outsourced Medical Device Testing can include a variety of tests, such as biocompatibility, electrical safety, and environmental testing. Some companies in the Outsourced Medical Device Testing market include Intertek, SGS, TÜV SÜD, UL, and BSI. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.